---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-141816"
form_type: "8-K"
ticker: "FNCHQ"
cik: "0001733257"
company_name: "Finch Therapeutics Group, Inc."
filed_at: "2024-05-17T23:59:59+00:00"
generated_at: "2026-06-01T16:18:47.633957+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Finch Therapeutics receives additional delisting notice, requests transfer to Nasdaq Capital Market

## Summary
- Nasdaq issued Additional Staff Determination on May 14, 2024, for continued noncompliance with $5M MVPHS Rule.
- Company failed to regain compliance by May 13, 2024 deadline; first flagged Nov 15, 2023.
- Company also deemed a 'public shell'; appeal hearing held April 23, 2024, decision pending.
- On May 15, 2024, Company requested transfer from Nasdaq Global Select to Nasdaq Capital Market; no guarantee of approval.

## SEC filing metadata
- accession: 0001193125-24-141816
- form_type: 8-K
- ticker: FNCHQ
- cik: 0001733257
- company_name: Finch Therapeutics Group, Inc.
- filed_at: 2024-05-17T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1733257/000119312524141816/0001193125-24-141816-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1733257/000119312524141816/d800582d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-141816
- JSON: https://secwatch.observer/filing/0001193125-24-141816.json
- Plain text: https://secwatch.observer/filing/0001193125-24-141816.txt

## Key facts
- Listing & Compliance Notices
  Finch Therapeutics Group, Inc. received a nasdaq delisting notice notice regarding market value (rules 5450(b)(1)(C)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: market value
  - Rules: 5450(b)(1)(C)
  source text: May 14, 2024, the Nasdaq Listing Qualifications Department issued an Additional Staff Determination that the Company’s continued noncompliance with the MVPHS Rule serves as an additional basis for delisting the Common Stock from The Nasdaq Global Select Market. Also as previously disclosed, the Company previously received a determination letter from the Nasdaq Listing Qualifications Department informing the Company of Nasdaq’s belief that the Company is a “public shell” under the Nasdaq criteria. The Company appealed the Nasdaq Listing Qualifications Department’s determination with respect to
  evidence_url: https://www.sec.gov/Archives/edgar/data/1733257/000119312524141816/0001193125-24-141816-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.